Clinicopathological and prognostic value of microRNA-21 and microRNA-155 in colorectal cancer

Oncology

Volumn 79, Issue 3-4, 2011, Pages 313-320

  Shibuya, Hajime ^a   Iinuma, Hisae ^a   Shimada, Ryu ^a   Horiuchi, Atsushi ^a   Watanabe, Toshiaki ^a  

^a TEIKYO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Colorectal cancer; MicroRNA 155; MicroRNA 21; PDCD4; Prognostic factor; TP53INP1

Indexed keywords

MEMBRANE PROTEIN; MICRORNA 155; MICRORNA 21; PROGRAMMED CELL DEATH 4; RNA; TUMOR MARKER; TUMOR PROTEIN; TUMOR PROTEIN 53 INDUCED NUCLEAR PROTEIN 1; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER INVASION; CANCER PATIENT; CANCER SURVIVAL; COLORECTAL CANCER; CONTROLLED STUDY; DISEASE FREE SURVIVAL; FEMALE; GENE EXPRESSION; GENE OVEREXPRESSION; HISTOLOGY; HUMAN; HUMAN TISSUE; LIVER METASTASIS; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PERITONEUM METASTASIS; PRIORITY JOURNAL; PROGNOSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADULT; AGED; AGED, 80 AND OVER; APOPTOSIS REGULATORY PROTEINS; CARRIER PROTEINS; COLORECTAL NEOPLASMS; FEMALE; HEAT-SHOCK PROTEINS; HUMANS; LIVER NEOPLASMS; LYMPHATIC METASTASIS; MALE; MICRORNAS; MIDDLE AGED; NEOPLASM INVASIVENESS; PERITONEAL NEOPLASMS; PROGNOSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA-BINDING PROTEINS; SURVIVAL RATE;

EID: 79952577682     PISSN: 00302414     EISSN: None     Source Type: Journal    
DOI: 10.1159/000323283     Document Type: Article

References (35)

1. Shike M, Winawer SJ, Greenwald PH, Bloch A, Hill MJ, Swaroop SV: Primary prevention of colorectal cancer. The WHO Collaborat-ing Centre for the Prevention of Colorectal Cancer. Bull World Health Organ 1990; 68: 377-385.
2. Figueredo A, Coombes ME, Mukherjee S: Adjuvant therapy for completely resected stage II colon cancer. Cochrane Database Syst Rev 2008; 3:CD005390.
3. Aslam MI, Taylor K, Pringle JH, Jameson JS: MicroRNAs are novel biomarkers of colorectal cancer. Br J Surg 2009; 96:702-710.
4. Chen CZ, Li L, Lodish HF, Bartel DP: Mi-croRNAs modulate hematopoietic lineage differentiation. Science 2004; 303: 83-86. (Pubitemid 38055775)
5. Croce CM, Calin GA: miRNAs, cancer, and stem cell division. Cell 2005; 122: 6-7. (Pubitemid 40977933)
6. Caldas C, Brenton JD: Sizing up miRNAs as cancer genes. Nat Med 2005; 11: 712-714. (Pubitemid 41021196)
7. Calin GA, Dumitru CD, Shimizu M, Bichi R Zupo S, Noch E, Aldler H, Rattan S, Keating M, Rai K, Rassenti L, Kipps T, Negrini M, Bullrich F, Croce CM: Frequent deletions and down-regulation of micro-RNA genes miR15 and miR16 at 13q14 in chronic lym-phocytic leukemia. Proc Natl Acad Sci USA 2002; 99: 15524-15529. (Pubitemid 35403967)
8. Johnson SM, Grosshans H, Shingara J, By-rom M, Jarvis R, Cheng A, Labourier E, Reinert KL, Brown D, Slack FJ: RAS is regu-lated by the let-7 microRNA family. Cell 2005; 120:635-647. (Pubitemid 40343076)
9. Calin GA, Ferracin M, Cimmino A, DiLeva G, Shimizu M, Wojcik SE, Iorio MV, Visone R, Sever NI, Fabbri M, Iuliano R, Palumbo T, Pichiorri F, Roldo C, Garzon R, Sevignani C, Rassenti L, Alder H, Volinia S, Liu CG, Kipps TJ, Negrini M, Croce CM: A microRNA sig-nature associated with prognosis and pro-gression in chronic lymphocytic leukemia. N Engl J Med 2005; 353: 1793-1801. (Pubitemid 41549891)
10. He L, Thomson JM, Hemann MT, Hernan-do-Monge E, Mu D, Goodson S, Powers S, Cordon-Cardo C, Lowe SW, Hannon GJ, Hammond SM: A microRNA polycistron as a potential human oncogene. Nature 2005; 435:828-833. (Pubitemid 40839734)
11. Yan LX, Huang XF, Shao Q, Huang MY, Deng L, Wu QL, Zeng YX, Shao JY: Micro-RNA miR-21 overexpression in human breast cancer is associated with advanced clinical stage, lymph node metastasis and pa-tient poor prognosis. RNA 2008; 14: 2348-2360.
12. Asangani IA, Rasheed SA, Nikolova DA, Leupold JH, Colburn NH, Post S, Allgaver H: MicroRNA-21 (miR-21) post-transcrip-tionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer. Onco-gene 2008; 27:2128-2136. (Pubitemid 351485639)
13. Juang S, Zhang HW, Lu MH, He XH, Li Y, Gu H Liu MF, Wang ED: MicroRNA-155 func-tions as an oncomiR in breast cancer by tar-geting the suppressor of cytokine signaling 1 gene. Cancer Res 2010; 70:3119-3127.
14. Greither T, Grochola LF, Udelnow A, Lau-tenschlager C, Wurl P, Taubert H: Elevated expression of microRNAs 155, 203, 210 and 222 in pancreatic tumors is associated with poorer survival. Int J Cancer 2010; 126:73-80.
15. Raponi M, Dossey L, Jatkoe T, Wu X, Chen G, Fan H, Beer D: MicroRNA classifies for predicting prognosis of squamous cell lung cancer. Clin Res 2009; 69:5776-5783.
16. Roldo C, Missiaglia E, Hagan JP, Falconi M, Capelli P, Bersani S, Calin GA, Volinia S, Liu CG, Scarpa A, Croce CM: MicroRNA ex-pression abnormalities in pancreatic endo-crine and acinar tumors are associated with distinctive pathologic features and clinical behavior. J Clin Oncol 2006; 24:4677-4684. (Pubitemid 46630931)
17. Lu Z, Liu M, Stribinskis V, Klinge CM, Ra-mos KS, Colburn NH, Li Y: MicroRNA-21 promotes cell transformation by targeting the programmed cell death 4 gene. Onco-gene 2008; 27:4373-4379. (Pubitemid 352010003)
18. Chen Y, Liu W, Chao T, Zhang Y, Yan X Gong Y, Qiang B, Yuan J, Sun M, Peng X: Mi-croRNA-21 down-regulates the expression of tumor suppressor PDCD4 in human glio-blastoma cell T98G. Cancer Lett 2008; 272: 197-205.
19. Goke R Gregel C, Goke A, Arnold R Schmidt H, Lankat-Buttgereit B: Pro-grammed cell death protein 4 (PDCD4) acts as a tumor suppressor in neuroendocrine tu-mor cells. Ann NY Acad Sci 2004; 1014:220-222.
20. Jansen AP, Camalier CE, Colburn NH: Epi-dermal expression of the translation inhibi-tor programmed cell death 4 suppresses tu-morigenesis. Cancer Res 2005; 65:6034-6041. (Pubitemid 40994387)
21. Lankat-Buttgereit B, Gregel C, Knolle A, Hasilik A, Arnold R Goke R: Pdcd4 inhibits growth of tumor cells by suppression of car-bonic anhydrase type II. Mol Cell Endocri-nol 2004; 214:149-153. (Pubitemid 38210124)
22. Bitomsky N, Bohm M, Klempnauer KH: Transformation suppressor protein Pdcd4 interferes with JNK-mediated phosphoryla-tion of c-Jun and recruitment of the coactiva-tor p300 by c-Jun. Oncogene 2004; 23: 7484-7493. (Pubitemid 39389690)
23. Gironella M, Seux M, Xie MJ, Cano C, Toma-sini R, Gommeaux J, Garcia S, Nowak J, Yeung ML, Jeang KT, Chaix A, Fazli L, Mo-too Y Wang Q, Rocchi P, Russo A, Gleave M, Dagorn JC, Iovanna JL, Carrier A, Pébusque MJ, Dusetti NJ: Tumor protein 53-induced nuclear protein 1 expression is repressed by miR-155 and its restoration inhibits pancre-atic tumor development. Proc Natl Acad Sci USA 2007; 104: 16170-16175. (Pubitemid 350099380)
24. Motoyama K, Inoue H, Mimori K, Tanaka F, Kojima K, Uetake H, Sugihara K, Mori M: Clinicopathological and prognostic signifi-cance of PDCD4 and microRNA-21 in hu-man gastric cancer. Int J Oncol 2010; 36: 1089-1095.
25. Lagos-Quintana M, Rauhut R, Meyer J, Borkhardt A, Tuschl T: New microRNAs from mouse and human. RNA 2003; 9: 175-179. (Pubitemid 36206285)
26. Slaby O, Svoboda M, Fabian P, Smerdova T, Knoflickova D, Bednarikova M, Nenutil R, Vyzula R: Altered expression of miR21, miR-31, miR-143 and miR-145 is related to clini-copathological features of colorectal cancer. Oncology 2007; 72: 397-402. (Pubitemid 351238155)
27. Chan JA, Krichevsky AM, Kosik KS: Mi-croRNA-21 is an antiapoptotic factor in hu-man glioblastoma cells. Cancer Res 2005; 65: 6029-6033. (Pubitemid 40994386)
28. Iorio MV, Ferracin M, Liu CG, Veronese A, Spizzo R, Sabbioni S, Magri E, Pedriali M, Fabbri M, Campiglio M, Menard S, Palazzo JP, Rosenberg A, Musiani P, Volinia S, Nenci I, Calin GA, Querzoli P, Negrini M, Croce CM: MicroRNA gene expression deregula-tion in human breast cancer. Cancer Res 2005; 65:7065-7070. (Pubitemid 41161233)
29. Meng F, Henson R, Wehbe-Janek H, Ghoshal K, Jacob ST, Patel T: MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer. Gas-troenterology 2007; 133: 647-658. (Pubitemid 47187346)
30. Schetter AJ, Leung SY, Sohn JJ, Zanetti KA, Bowman ED, Yanaihara N, Yuen ST, Chan TL, Kwong DL, Au GK, Liu CG, Calin GA, Croce CM, Harris CC: MicroRNA expres-sion profiles associated with prognosis and therapeutic outcome in colon adenocarcino-ma. JAMA 2008; 299:425-436. (Pubitemid 351185951)
31. Thai TH, Calado DP, Casola S, Ansel KM, Xiao C, Xue Y, Murphy A, Frendewey D, Va-lenzuela D, Kutok JL, Schmidt-Supprian M, Rajewsky N, Yancopoulos G, Rao A, Rajew-sky K: Regulation of the germinal center re-sponse by microRNA-155. Science 2007; 316: 604-608. (Pubitemid 46683147)
32. Ceppi M, Peraira PM, Dunand-Sauthier I, Barras E, Reith W, Santos MA, Pierre P: Mi-croRNA-155 modulates the interleukin-1 signaling pathway in activated human monocyte-derived dendritic cells. Proc Natl Acad Sci USA 2009; 106:2735-2740.
33. Yanaihara N, Caplen N, Bowman E, Seike M, Kumamoto K, Yi M, Stephens RM, Okamoto A, Yokota J, Tanaka T, Calin GA, Liu CG, Croce CM, Harris CC: Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. Cancer Cell 2006; 9: 189-198. (Pubitemid 43357945)
34. Tomasini R, Samir AA, Carrier A, Pebusque MJ, Calvo EL, Totaro S, Dagorn JC, Dusetti NJ, Iovanna JL: p53-dependent expression of the stress-induced protein (SIP). Eur J Cell Biol 2002; 81: 294-301. (Pubitemid 34568210)
35. Tomasini R, Samir AA, Carrier A, Isnar-don D, Cecchinelli B, Soddu S, Malissen B, Dagorn JC, Iovanna JL, Dusetti NJ: TP53INP1s and homeodomain-interacting protein kinase-2 (HIPK2) are partners in regulating p53 activity. J Biol Chem 2003; 178: 37722-37729. (Pubitemid 37175297)